Cornea/External Disease News

MILAN — Cellular therapy with adipose-derived mesenchymal stem cells implanted in the corneal stroma may be an alternative to corneal transplantation, according to a study presented here.

Man, this sure is not turning into one of those “nothing to see here” columns.

MONTEREY, Calif. — Women treated with Tyrvaya had consistent outcomes regardless of their menopause status, according to a study presented at the Women in Ophthalmology Summer Symposium.

MILAN — At the ESCRS meeting, Shigeru Kinoshita, MD, PhD, joined virtually a symposium on emerging treatment options for corneal endothelial disease.

MONTEREY, Calif. — A study carried out across seven centers in the U.S. found that ocular inflammation might occur in a minority of subjects after COVID-19 vaccination.

The Champalimaud Foundation has recognized Gerrit Melles, MD, PhD, and Claes H. Dohlman, MD, PhD, with its 2022 Vision Award for their research and treatment of corneal diseases, according to a press release.

MONTEREY, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Jennifer M. Loh, MD, discusses how cases of Demodex blepharitis can sometimes masquerade as severe dry eye disease.

The temporary shutdown of medical facilities for all but urgent and emergent care at the beginning of the COVID-19 pandemic resulted in delays in care for keratoconus.

Sight Sciences has completed enrollment in the SAHARA trial, which is evaluating the TearCare system to treat the signs and symptoms of dry eye disease, according to a press release.

MONTEREY, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Jennifer M. Loh, MD, discusses meibomian gland dysfunction in patients 1 month after TearCare treatment.